187 related articles for article (PubMed ID: 25734246)
1. Integration of gene expression and DNA-methylation profiles improves molecular subtype classification in acute myeloid leukemia.
Taskesen E; Babaei S; Reinders MM; de Ridder J
BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S5. PubMed ID: 25734246
[TBL] [Abstract][Full Text] [Related]
2. An integrated approach of gene expression and DNA-methylation profiles of WNT signaling genes uncovers novel prognostic markers in acute myeloid leukemia.
Taskesen E; Staal FJ; Reinders MJ
BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S4. PubMed ID: 25734857
[TBL] [Abstract][Full Text] [Related]
3. DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML).
Krali O; Palle J; Bäcklin CL; Abrahamsson J; Norén-Nyström U; Hasle H; Jahnukainen K; Jónsson ÓG; Hovland R; Lausen B; Larsson R; Palmqvist L; Staffas A; Zeller B; Nordlund J
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200630
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.
Figueroa ME; Lugthart S; Li Y; Erpelinck-Verschueren C; Deng X; Christos PJ; Schifano E; Booth J; van Putten W; Skrabanek L; Campagne F; Mazumdar M; Greally JM; Valk PJ; Löwenberg B; Delwel R; Melnick A
Cancer Cell; 2010 Jan; 17(1):13-27. PubMed ID: 20060365
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.
Li Y; Xu Q; Lv N; Wang L; Zhao H; Wang X; Guo J; Chen C; Li Y; Yu L
J Hematol Oncol; 2017 Feb; 10(1):41. PubMed ID: 28153026
[TBL] [Abstract][Full Text] [Related]
6. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
[TBL] [Abstract][Full Text] [Related]
7. Classification of pediatric acute myeloid leukemia based on miRNA expression profiles.
Obulkasim A; Katsman-Kuipers JE; Verboon L; Sanders M; Touw I; Jongen-Lavrencic M; Pieters R; Klusmann JH; Michel Zwaan C; van den Heuvel-Eibrink MM; Fornerod M
Oncotarget; 2017 May; 8(20):33078-33085. PubMed ID: 28380436
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
9. Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisited.
Obulkasim A; Fornerod M; Zwaan MC; Reinhardt D; van den Heuvel-Eibrink MM
BMC Bioinformatics; 2015 Sep; 16():305. PubMed ID: 26399969
[TBL] [Abstract][Full Text] [Related]
10. Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML?
Willman CL
Best Pract Res Clin Haematol; 2008 Mar; 21(1):21-8. PubMed ID: 18342809
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.
Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J
Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles.
Schoch C; Kohlmann A; Schnittger S; Brors B; Dugas M; Mergenthaler S; Kern W; Hiddemann W; Eils R; Haferlach T
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10008-13. PubMed ID: 12105272
[TBL] [Abstract][Full Text] [Related]
13. The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.
Eisfeld AK; Mrózek K; Kohlschmidt J; Nicolet D; Orwick S; Walker CJ; Kroll KW; Blachly JS; Carroll AJ; Kolitz JE; Powell BL; Wang ES; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
Leukemia; 2017 Oct; 31(10):2211-2218. PubMed ID: 28321123
[TBL] [Abstract][Full Text] [Related]
14. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.
Verhaak RG; Wouters BJ; Erpelinck CA; Abbas S; Beverloo HB; Lugthart S; Löwenberg B; Delwel R; Valk PJ
Haematologica; 2009 Jan; 94(1):131-4. PubMed ID: 18838472
[TBL] [Abstract][Full Text] [Related]
15. Array-based DNA methylation profiling in acute myeloid leukaemia.
Wilop S; Fernandez AF; Jost E; Herman JG; Brümmendorf TH; Esteller M; Galm O
Br J Haematol; 2011 Oct; 155(1):65-72. PubMed ID: 21790528
[TBL] [Abstract][Full Text] [Related]
16. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling in MDS and AML: potential and future avenues.
Theilgaard-Mönch K; Boultwood J; Ferrari S; Giannopoulos K; Hernandez-Rivas JM; Kohlmann A; Morgan M; Porse B; Tagliafico E; Zwaan CM; Wainscoat J; Van den Heuvel-Eibrink MM; Mills K; Bullinger L
Leukemia; 2011 Jun; 25(6):909-20. PubMed ID: 21445077
[TBL] [Abstract][Full Text] [Related]
18. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
Verhaak RG; Valk PJ
Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells.
Spencer DH; Young MA; Lamprecht TL; Helton NM; Fulton R; O'Laughlin M; Fronick C; Magrini V; Demeter RT; Miller CA; Klco JM; Wilson RK; Ley TJ
Leukemia; 2015 Jun; 29(6):1279-89. PubMed ID: 25600023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
